Scientists gear up for trials of insulin devices developed from pig-derived pancreas cells
This article was originally published in Clinica
Executive Summary
Researchers in the US are close to starting trials of implanted devices which use pig-derived pancreas cells to produce insulin for diabetics. These devices could be a long-term answer to replacing the pancreas and provide a readily available treatment for sufferers of the condition.